DNA X Inc

SONM

Market cap $4.69M

SONM Hedge Fund Activity: Q1 2026 in Review

9 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q1 2026, worth a combined $384K — up 44% from $266K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new SONM positions and 4 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $130K. The largest seller was Potomac Capital Management, exiting entirely with an estimated $151K sold.

• 9 institutional investors held DNA X Inc (SONM) as of Q1 2026, up from 8 in Q4 2025.
• Funds reported $384K of DNA X Inc stock for Q1 2026, up 44% quarter-over-quarter.
• 5 funds opened new DNA X Inc positions in Q1 2026 and 4 closed out, a net change of +1 holder.
• The largest DNA X Inc buyer in Q1 2026 was UBS Group, an estimated $130K added.
• The largest DNA X Inc seller in Q1 2026 was Potomac Capital Management, an estimated $151K sold.

Based on aggregated 13F filings for Q1 2026.